Transcription Factor |
Target ORF/Genes |
References |
Evidence Code |
Evidence Experiment |
Association Type |
Strain |
Environmental Condition |
Gln3p
|
YJR152W
|
PubMed
Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8Cooper TG et al., J Bacteriol, 1990 Feb;172(2):1014-8 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
AM100 |
Minimal glucose proline medium |
PubMed
Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13Cox KH et al., Yeast, 1999 Jun 15;15(8):703-13 |
Indirect |
Microarray analysis - WT vs TF mutant |
Negative |
TCY1 |
Wickerham's minimal medium with 0,6% glucose and 0,1% of proline |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Hirasaki M et al., Gene, 2008;():Hirasaki M et al., Gene, 2008;(): |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
YPAD + 14mM Caffeine 1h |
PubMed
Georis I et al., J Biol Chem, 2008 Apr 4;283(14):8919-29Georis I et al., J Biol Chem, 2008 Apr 4;283(14):8919-29 |
Indirect |
Northern blot - WT vs TF mutant |
Positive |
S288c |
glutamine |
PubMed
Georis I et al., Genetics, 2009 Mar;181(3):861-74Georis I et al., Genetics, 2009 Mar;181(3):861-74 |
Direct |
ChIP |
N/A |
25T0b, FV090, FV069, FV076, FV041, 03803c |
YNB-glutamine medium treated with rapamycin (0.2 microg/ml) for 30 min |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
FV022 |
YNB-glutamine medium treated with rapamycin (0.2 microg/ml) for 30 min |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - WT vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Georis I et al., Mol Cell Biol, 2011 Jan;31(1):92-104Georis I et al., Mol Cell Biol, 2011 Jan;31(1):92-104 |
Direct |
ChIP |
N/A |
S288c |
Rapamycin treatment |
PubMed
Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64Hernández H et al., Biochem Biophys Res Commun, 2011 Jan 21;404(3):859-64 |
Direct |
ChIP |
N/A |
S288c |
3-aminotriazole |
PubMed
Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912Georis I et al., J Biol Chem, 2011 Dec 30;286(52):44897-912 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
Rapamycin treatment |
PubMed
Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
cells grown in YPD medium and then treated with rapamycin o transferred to proline medium. |
PubMed
Numamoto M et al., J Biosci Bioeng, 2015 Aug;120(2):121-7Numamoto M et al., J Biosci Bioeng, 2015 Aug;120(2):121-7 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
DELTAgln3 carrying or not a plasmid pRS316-GLN3S391D-Myc13 incubated in YPDA medium, supplemented with 5 mM caffeine for 30 min |
PubMed
Fayyad-Kazan M et al., Mol Microbiol, 2016 Jan;99(2):360-79Fayyad-Kazan M et al., Mol Microbiol, 2016 Jan;99(2):360-79 |
Indirect |
RT-PCR - WT vs TF mutant |
Positive |
S288c |
cells were grown in am or ammonium (1%) + glutamine (0.1% w/v) medium. |
PubMed
González J et al., Genetics, 2017 Nov;207(3):975-991González J et al., Genetics, 2017 Nov;207(3):975-991 |
Direct |
ChIP |
N/A |
CLA11-700 |
Cells grown to OD600 0.5 on MM with 2% glucose with VIL (valine plus isoleucine plus leucine) (catabolic conditions) |
Direct |
ChIP |
N/A |
CLA11-700 |
Cells grown to OD600 0.5 on MM with 2% glucose with GABA |